Bone Biologics
(NASDAQ:BBLG)
$2.19
-0.24[-9.88%]
At close: Mar 4
$2.19
0[0.00%]
PreMarket: 7:29AM EDT

GET A REPORT ON BBLG SENT RIGHT TO YOUR INBOX

Bone Biologics Stock (NASDAQ:BBLG), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$2.25
Lowest Price Target1
$2.25
Consensus Price Target1
$2.25

Analyst Rating Summary1

Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Bone Biologics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
04/13/2023BBLGBuy Now
Bone Biologics
$2.192.74%EF Hutton
Constantine Davides
→ $540Reiterates → BuyGet Alert
04/03/2023BBLGBuy Now
Bone Biologics
$2.192.74%EF Hutton
Constantine Davides
→ $540Reiterates → BuyGet Alert
10/18/2022BBLGBuy Now
Bone Biologics
$2.192.74%EF Hutton
Constantine Davides
→ $540Initiates → BuyGet Alert

FAQ

Q

What is the target price for Bone Biologics (BBLG)?

A

The latest price target for Bone Biologics (NASDAQ: BBLG) was reported by EF Hutton on April 13, 2023. The analyst firm set a price target for $2.25 expecting BBLG to rise to within 12 months (a possible 2.74% upside). 2 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Bone Biologics (BBLG)?

A

The latest analyst rating for Bone Biologics (NASDAQ: BBLG) was provided by EF Hutton, and Bone Biologics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Bone Biologics (BBLG)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bone Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bone Biologics was filed on April 13, 2023 so you should expect the next rating to be made available sometime around April 13, 2024.

Q

Is the Analyst Rating Bone Biologics (BBLG) correct?

A

While ratings are subjective and will change, the latest Bone Biologics (BBLG) rating was a reiterated with a price target of $0.00 to $2.25. The current price Bone Biologics (BBLG) is trading at is $2.19, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch